<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03662399</url>
  </required_header>
  <id_info>
    <org_study_id>NPD85301</org_study_id>
    <nct_id>NCT03662399</nct_id>
  </id_info>
  <brief_title>Francis Biomechanics Study</brief_title>
  <official_title>A Single Centre, Cross-over Study to Evaluate the Effect of a Range of Pre-formed Orthoses on Function of the Foot and Leg to Generate Technical Data on How the Individual Insoles Impact Gait, Distribution of Load and Stability in a Healthy Population.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reckitt Benckiser Healthcare (UK) Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Reckitt Benckiser Healthcare (UK) Limited</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the effect of a range of pre-formed orthoses on function of the
      foot and leg to generate technical data on how the individual insoles impact gait,
      distribution of load and stability in a healthy population.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 13, 2018</start_date>
  <completion_date type="Actual">August 10, 2018</completion_date>
  <primary_completion_date type="Actual">August 10, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>In shoe dynamic pressure (shock absorption and loading pattern) Impact on Gait</measure>
    <time_frame>2 hours</time_frame>
    <description>Peak pressure (PP)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>In shoe dynamic pressure (shock absorption and loading pattern) Impact on Gait</measure>
    <time_frame>2 hours</time_frame>
    <description>Pressure time integral (PTI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>In shoe dynamic pressure (shock absorption and loading pattern) Impact on Gait</measure>
    <time_frame>2 hours</time_frame>
    <description>Force time integral (FTI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>In shoe dynamic pressure (shock absorption and loading pattern) Impact on Gait</measure>
    <time_frame>2 hours</time_frame>
    <description>Contact area (CA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>In shoe dynamic pressure (shock absorption and loading pattern) Impact on Gait</measure>
    <time_frame>2 hours</time_frame>
    <description>Time to peak pressure (TPP)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>In shoe dynamic pressure (shock absorption and loading pattern) Impact on Gait</measure>
    <time_frame>2 hours</time_frame>
    <description>Contact time (CT)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>In shoe dynamic pressure (shock absorption and loading pattern) Impact on Gait</measure>
    <time_frame>2 hours</time_frame>
    <description>Centre of pressure (balance/stability)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3D gait analysis</measure>
    <time_frame>2 hours</time_frame>
    <description>Rearfoot angle at contact</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3D gait analysis</measure>
    <time_frame>2 hours</time_frame>
    <description>Maximum rearfoot angle</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3D gait analysis</measure>
    <time_frame>2 hours</time_frame>
    <description>Rearfoot excursion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3D gait analysis</measure>
    <time_frame>2 hours</time_frame>
    <description>Rearfoot eversion velocity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3D gait analysis</measure>
    <time_frame>2 hours</time_frame>
    <description>Stride Velocity (m/s)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3D gait analysis</measure>
    <time_frame>2 hours</time_frame>
    <description>Tibial rotation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3D gait analysis</measure>
    <time_frame>2 hours</time_frame>
    <description>Displacement of centre of mass</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3D gait analysis</measure>
    <time_frame>2 hours</time_frame>
    <description>Hip drop</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3D gait analysis</measure>
    <time_frame>2 hours</time_frame>
    <description>Thoracic rotation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3D gait analysis</measure>
    <time_frame>2 hours</time_frame>
    <description>Hip drop velocity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3D gait analysis</measure>
    <time_frame>2 hours</time_frame>
    <description>Thoracic rotation velocity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3D gait analysis</measure>
    <time_frame>2 hours</time_frame>
    <description>kinetic data. This includes vertical force, vertical impulse, ankle inversion moment, ankle eversion moment, knee adduction moment, hip adduction moment and hip abduction moment (maximums, measured in BW).</description>
  </primary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Healthy Subject</condition>
  <arm_group>
    <arm_group_label>Insole A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational product - Insole A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insole B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational product - Insole B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insole C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational product - Insole C</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insole D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational product - Insole D</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insole E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational product - Insole E</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insole F</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational product - Insole F</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insole G</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Non-Investigational product - Standard shoe</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Insoles</intervention_name>
    <description>Orthotic Insoles</description>
    <arm_group_label>Insole A</arm_group_label>
    <arm_group_label>Insole B</arm_group_label>
    <arm_group_label>Insole C</arm_group_label>
    <arm_group_label>Insole D</arm_group_label>
    <arm_group_label>Insole E</arm_group_label>
    <arm_group_label>Insole F</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard shoe</intervention_name>
    <description>Standard shoe</description>
    <arm_group_label>Insole G</arm_group_label>
    <other_name>Non-Investigational product</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy male and female subjects between the ages of 18-60 years inclusive.

          2. Subjects who are able to give written informed consent.

          3. Subjects who are able to understand the study, cooperate with the study procedures and
             are able to attend all study assessments.

          4. Subjects who are willing to wear a t-shirt and shorts during the study assessments.

          5. Subjects who are willing and able to stand for a minimum of two hours at a time during
             the study assessments.

          6. Subject with shoe size between 4.5 to 11 (UK) / 37 to 45 (European).

          7. Subjects who can achieve the acceptable fit of standard shoes.

          8. Subjects who do not have any walking impairments and can walk without distress. This
             will be determined through walking at a speed of 3-5 kmph for a distance of 30 m.

          9. Subjects with a Foot Posture Index (FPI) between 6 and 9 showing mild pronation as
             determined by the study Investigator or designees.

         10. Subjects with a BMI between 18.5 - 24.9 kg/m2.

        Exclusion Criteria:

          1. Subjects who are pregnant or who have given birth within the last 6 months.

          2. Subjects who have a medical condition that could compromise the use of the orthotic
             insoles (peripheral vascular disease or sensory neuropathy).

          3. Subjects that have Leg Length Discrepancy (LLD) of more than 5 mm. This will be
             determined using the Downings Sign (7), a test which is used to establish actual
             versus functional LLD. This will be cross-referenced with anatomical land marks.

          4. Subjects that use prescribed or self-administrated orthotics to correct biomechanical
             or other issues.

          5. Subject that have received any previous orthotic treatment.

          6. Subjects who have a current or previous injury that has prevented their usual
             activities for more than 3 weeks in the last year.

          7. Subjects with history of lower limb or foot surgery, inflammatory disease,
             neurological disease, diabetes, leg ulceration, skin grafts or any other condition
             that in the opinion of the Investigator or designees could interfere with the
             assessments in this study.

          8. Subjects having ischemia or poor blood supply to the feet, Charcot Arthropathy,
             autoimmune disease (e.g. rheumatoid arthritis) and connective tissue disease (e.g.
             scleroderma).

          9. Subjects demonstrating symptoms of macrovascular diseases (e.g. angina, stroke).

         10. Individuals suffering from other conditions affecting the feet, such as infectious
             foot conditions, which in the opinion of the Investigator or designees, would
             interfere with the generation of data and risk the spread of infection to other
             subjects through the use of the standard shoe.

         11. Individuals with broken/irritated or damaged skin on their feet.

         12. Individuals suffering from relevant product allergies or sensitivities.

         13. Individuals who have consulted a healthcare professional for a gait related or foot
             pain issue.

         14. Individuals who were previously in another clinical study within the last 3 months
             prior to screening assessment.

         15. Employees who are directly involved with the study at study site.

         16. Any partner or first degree relative of anyone that has a role in the study at the
             CRO/Site/Sponsor.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>40-60% Male and female recruitment</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-François Kaux, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Liège, Avenue de L'Hòpital , Belgium</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Liège, Avenue de L'Hòpital</name>
      <address>
        <city>Liège</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>June 6, 2018</study_first_submitted>
  <study_first_submitted_qc>September 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2018</study_first_posted>
  <last_update_submitted>September 5, 2018</last_update_submitted>
  <last_update_submitted_qc>September 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

